ProtocolType from the Guide heading
Identified from the heading: heading begins with Protocol/Specifications.
Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 579 · page 1 of 3 of this heading
Protocol for Medication Controlled
Metabolic Syndrome
(Glucose Intolerance, Impaired Glucose tolerance, Impaired Fasting Glucose,
Insulin Resistance, and Pre-Diabetes)
(Updated 07/26/2023)
An applicant with a diagnosis of diabetes mellitus treated with a medication not
including insulin may be considered by the FAA for an Authorization of a Special
Issuance of a Medical Certificate (Authorization). For medications currently allowed and
required observation times, see chart of Acceptable Combinations of Diabetes
Medications.
The initial Authorization decision is made by the AMCD and may not be made by the
AME. An AME may re-issue a subsequent airman medical certificate under the
provisions of the Authorization.
The initial Authorization determination will be made on the basis of a report from the
treating physician. There must be sufficient information to rule out diabetes mellitus.
For favorable consideration, the report must contain a statement regarding the
medication used, dosage, the absence or presence of side effects and clinically
significant hypoglycemic episodes, and an indication of satisfactory control of the
metabolic syndrome. The results of an A1C hemoglobin determination within the past
30 days must be included. Note must also be made of the presence of cardiovascular,
neurological, renal, and/or ophthalmological disease. The presence of one or more of
these associated diseases will not be, per se, disqualifying but the disease(s) must be
carefully evaluated to determine any added risk to aviation safety.
Re-issuance of a medical certificate under the provisions of an Authorization will also be
made on the basis of reports from the treating physician. The contents of the report
must contain the same information required for initial issuance and specifically
reference the presence or absence of satisfactory control, any change in the dosage or
type of medication, and the presence or absence of complications or side effects from
the medication. In the event of an adverse change in the applicant's status
(development of diabetes mellitus, poor control or complications or side effects from the
medication), or the appearance of an associated systemic disease, an AME must defer
the case with all documentation to the AMCD for consideration.
If, upon further review of the deferred case, AMCD decides that re-issuance is
appropriate, the AME may again be given the authority to re-issue the medical
certificate under the provisions of the Authorization based on data provided by the
treating physician, including such information as may be required to assess the status of
associated medical condition(s).
At a minimum, follow-up evaluation by the treating physician of the applicant's metabolic
syndrome status is required annually for all classes of medical certificates.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source. Types such as “Protocol” are reading aids; AME Copilot does not make certification decisions.